Abraham Aserin

Title: The Innovative Contributions of Abraham Aserin

Introduction

Abraham Aserin is a notable inventor based in Jerusalem, Israel, recognized for his significant contributions to the field of pharmaceutical delivery systems. With a total of seven patents to his name, Aserin has made strides in developing innovative solutions that enhance the efficacy and safety of drug delivery.

Latest Patents

Among his latest patents, Aserin has developed novel dilutable delivery systems for propofol, which include microemulsions suitable for intravenous delivery. This advancement aims to improve the administration of propofol, a widely used anesthetic. Another significant patent involves reverse hexagonal mesophase liquid crystals, which provide multi-component hexagonal systems for solubilizing and protecting bio-macromolecules and active materials. This invention has therapeutic and non-therapeutic applications, including an oral delivery system that is adapted for effective oral administration. The formation of mesophase systems of ternary glycerol monooleate and water combinations, which incorporate biomacromolecules or drugs, is a key feature of this patent.

Career Highlights

Aserin has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Nutralease Ltd. His work in these companies has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Throughout his career, Aserin has collaborated with esteemed colleagues such as Nissim Garti and Aviram Spernath. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Abraham Aserin's innovative work in drug delivery systems has made a significant impact in the pharmaceutical field. His patents reflect a commitment to improving medical treatments and enhancing patient care through advanced technology.